The number of adverse events related to contrast-enhanced CT are not statistically different between patients who fasted or who ate beforehand.
It may not be necessary for cancer patients to fast prior to undergoing contrast-enhanced CT, according to a study published in the American Journal of Roentgenology.
Researchers from Brazil performed a prospective study to evaluate the effects of preparative fasting prior to contrast-enhanced CTs for patients with cancer. A total of 3,206 patients were randomly assigned to one of two groups; 1,619 fasted for at least 4 hours prior to their procedure and 1,587 consumed a light meal before undergoing the scan.
The results showed 45 patients (1.5 percent) in the fasting group reported adverse events, compared with 30 patients (0.9 percent) in the non-fasting group. The most common adverse events were:
• Nausea: 32 patients
• Weakness: 12 patients
• Vomiting: 5 patients
The authors noted that the frequency of symptoms between the two groups did not differ statistically significantly.
They concluded that among their sample group, there were few adverse reactions associated with eating a light meal before undergoing a CT scan with an IV contrast agent. “These results support the idea that preparation for contrast-enhanced CT can be simplified, decreasing the discomfort and inconvenience experienced by patients,” they wrote.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
Systematic Review: PET/MRI May be More Advantageous than PET/CT in Cancer Imaging
July 18th 2024While PET/MRI and PET/CT had comparable sensitivity for patient-level regional nodal metastases and lesion-level recurrence, the authors of a systematic review noted that PET/MRI had significantly higher accuracy in breast cancer and colorectal cancer staging.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Enhanced Mobile CT System with High-Resolution Photon-Counting Technology
July 15th 2024Photon-counting CT-optimized features with the OmniTom Elite system include 30 cm field of view scanning, continuous spiral scanning, and an ultra-high-resolution capability of 0.141 mm resolution.